| Financial Year |
March 31 2023 |
| Monetary Funds |
962,439,123.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
148,986,723.21 |
| Advances to Suppliers |
26,886,542.20 |
| Other Receivables |
67,783,247.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
26,926,027.41 |
| Inventories |
25,934,122.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
200,000,000.00 |
| Other Current Assets |
6,834,432.02 |
| Total Current Assets |
1,438,864,191.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
245,577,798.01 |
| Investment Properties |
42,666,311.98 |
| Fixed Assetes |
857,915,960.82 |
| Under-construction Projects |
337,061,555.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,272,028.16 |
| R&D expenses |
-- |
| Goodwill |
50,277,124.57 |
| Long-Term Deferred and Prepaid Expenses |
326,488,149.32 |
| Deferred Income Tax Assets |
13,060,803.53 |
| Other Non-Current Assets |
774,099,539.91 |
| Sub-Total of Non-Current Assets |
4,129,220,131.82 |
| Total Assets |
5,568,084,323.16 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
126,452,250.27 |
| Accounts Received In Advance |
171,088.01 |
| Employee Compensation Payable |
7,198,947.71 |
| Taxes Payable |
124,691,291.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,380,808.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
142,953,438.45 |
| Other Current Liabilities |
748,907.79 |
| Sub-Total of Current Liabilities |
441,510,774.17 |
| Long-term Loans |
280,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,899,566.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,310,808,959.60 |
| Total Liabilities |
1,752,319,733.77 |
| Paid-In Capital(Or Share Stock) |
320,640,000.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
72,290,268.42 |
| LESS:Treasury Stock |
99,985,812.47 |
| Undistributed Profits |
3,167,184,582.42 |
| Minority Stockholder's Interest |
336,046,597.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,479,717,992.05 |
| Owner's Equity（Stockholder's Equity） |
3,815,764,589.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,568,084,323.16 |
